electroCore, Inc. (NASDAQ:ECOR – Get Free Report) Director Daniel Goldberger sold 80,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 23rd. The shares were sold at an average price of $6.80, for a total value of $544,000.00. Following the completion of the sale, the director directly owned 211,471 shares in the company, valued at approximately $1,438,002.80. The trade was a 27.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.
electroCore Price Performance
NASDAQ ECOR opened at $10.25 on Friday. The company has a market cap of $85.08 million, a PE ratio of -5.79 and a beta of 0.83. The stock’s 50 day simple moving average is $7.32 and its 200-day simple moving average is $6.40. electroCore, Inc. has a 1-year low of $4.16 and a 1-year high of $10.45.
electroCore (NASDAQ:ECOR – Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported ($0.59) earnings per share for the quarter, meeting the consensus estimate of ($0.59). electroCore had a negative return on equity of 1,956.38% and a negative net margin of 44.08%.The business had revenue of $9.58 million for the quarter, compared to the consensus estimate of $9.01 million. On average, equities research analysts anticipate that electroCore, Inc. will post -1.48 EPS for the current fiscal year.
Institutional Inflows and Outflows
Analyst Ratings Changes
Several research analysts have recently issued reports on the company. Zacks Research raised electroCore from a “strong sell” rating to a “hold” rating in a research report on Friday, March 27th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of electroCore in a research note on Friday, March 27th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $18.00.
Get Our Latest Stock Analysis on electroCore
electroCore Company Profile
electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.
The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.
Featured Stories
- Five stocks we like better than electroCore
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.
